Teladoc Health (TDOC) said Thursday it has signed a pharmacy integration agreement with Eli Lilly's (LLY) LillyDirect pharmacy partner Gifthealth to provide self-pay option for obesity drug Zepbound.
The company said its members, who are enrolled in its comprehensive weight care program and don't have insurance coverage for glucagon-like peptide-1 receptor agonists for obesity, can have single-use Zepbound vials delivered to their homes.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。